e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Tuberculin skin tests, interferon-gamma release assays and beyond
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases
C. Martyn-Simmons, J. Mee, R. Groves, H. Milburn (London, United Kingdom)
Source:
Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Session:
Tuberculin skin tests, interferon-gamma release assays and beyond
Session type:
Poster Discussion
Number:
309
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Martyn-Simmons, J. Mee, R. Groves, H. Milburn (London, United Kingdom). Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases. Eur Respir J 2011; 38: Suppl. 55, 309
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Detection of IFN-γ responses for diagnosis of tuberculosis infection in chronic inflammatory disease patients
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011
Clinical relevance of Mycobacterium simiae in pulmonary samples
Source: Eur Respir J 2008; 31: 106-109
Year: 2008
Impact of T-SPOT.
TB
test to exclude active
Mycobacterium tuberculosis
complex infection in patients with mycobacterial disease
Source: Eur Respir J 2006; 28: Suppl. 50, 139s
Year: 2006
IgG-mediated humoral immune response against different mycobacterial antigens in tuberculosis (TB) and mycobacterial infections other than tuberculosis (MOTT)
Source: Eur Respir J 2001; 18: Suppl. 33, 307s
Year: 2001
Multiple cytokine response to
mycobacterium tuberculosis
with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014
Comparison of effector T-cell responses in patients with active TB disease compared to latent TB infection
Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Year: 2007
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement
Source: Eur Respir J 2009; 33: 956-973
Year: 2009
Different genetics background of patients with latent tuberculosis infection versus active tuberculosis
Source: International Congress 2017 – Asthma genetics and genomics in patients and populations
Year: 2017
Latent tuberculosis infection treatment in subjects with autoimmune diseases and T-cell interferon-γ responses
Source: Annual Congress 2009 - Frontiers in the diagnosis of tuberculosis
Year: 2009
Accidental detection of mycobacterium tuberculosis infection in patients with various respiratory diseases
Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control
Year: 2008
Utility of Th1-cell immune responses in differentiating active tuberculosis from latent tuberculosis infection
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014
How should we treat latent tuberculosis infection?
Source: Annual Congress 2003 - Latent tuberculosis infection - preventive approaches
Year: 2003
Utility of mycobacterium tuberculosis Rv0081-specific host gene expression to distinguish latent infection from active tuberculosis disease
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
Latent tuberculosis infection as a cause of tuberculosis disease
Source: Eur Respir J 2003; 22: Suppl. 45, 157s
Year: 2003
New skin test with recombinant protein CFP10-ESAT6 in patients (children and adults) with tuberculosis, non-tuberculosis disease and latent TB infection
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012
Paradoxical reactions in non-HIV tuberculosis presenting as endobronchial obstruction
Source: Eur Respir Rev 2009; 18: 295-299
Year: 2009
Increased frequencies of pulmonary regulatory T-cells in latent Mycobacterium tuberculosis infection
Source: Eur Respir J 2012; 40: 1450-1457
Year: 2012
The definition of tuberculosis infection based on the spectrum of tuberculosis disease
Source: Breathe, 17 (3) 210079; 10.1183/20734735.0079-2021
Year: 2021
Intensity of exposure to pulmonary tuberculosis determines risk of tuberculosis infection and disease
Source: Eur Respir J, 51 (1) 1701578; 10.1183/13993003.01578-2017
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept